Trials / Completed
CompletedNCT00140881
A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 2 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
A 53-week study to determine the effect of montelukast sodium when given to children (with infrequent episodic asthma) at the earliest symptoms of an acute episode of asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476; montelukast sodium | |
| DRUG | Comparator: placebo |
Timeline
- Start date
- 2000-06-01
- Primary completion
- 2003-02-14
- Completion
- 2003-02-14
- First posted
- 2005-09-01
- Last updated
- 2024-08-14
Source: ClinicalTrials.gov record NCT00140881. Inclusion in this directory is not an endorsement.